iTonic(ITOC.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
iTonic
ITOC.US
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd.
61.07 B
ITOC.USMarket value -Rank by Market Cap -/-

Financial Score

29/01/2026 Update
D
Health Care TechnologyIndustry
Industry Ranking39/46
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-101.64%E
    • Profit Margin-790.57%E
    • Gross Margin79.02%A
  • Growth ScoreD
    • Revenue YoY-46.67%E
    • Net Profit YoY-444.99%E
    • Total Assets YoY275.62%A
    • Net Assets YoY29159.22%A
  • Cash ScoreD
    • Cash Flow Margin-12.65%D
    • OCF YoY-46.67%E
  • Operating ScoreE
    • Turnover0.09E
  • Debt ScoreA
    • Gearing Ratio7.48%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    iTonic Holdings Appoints Bin Wu as Independent Director Replacing Yun Fai Wong

    iTonic Holdings Ltd. has appointed Bin Wu as an independent director, replacing Yun Fai Wong, who resigned for personal reasons. Wu will take over Wong's roles on the Audit Committee, Corporate Governance and Nominating Committee, and Compensation Committee, and will also chair the Corporate Governance and Nominating Committee.

    Reuters·
    US
    ITOC
    -2.88%
    Reuters·
    US
    ITOC
    -2.88%

    Pre-market hot trades in US stocks: iTonic pre-market down 11.31%; Ping An Biomedical pre-market up 11.01%

    iTonic pre-market down 11.31%; Ping An Biomedical pre-market up 11.01%; INVO Fertility pre-market up 340.67%; FuYuan Group pre-market up 123.28%; Black Titan pre-market up 84.12%

    Tracking Unusual Activity·
    US
    ITOC
    -2.88%
    US
    PASW
    -8.68%
    Tracking Unusual Activity·
    US
    ITOC
    -2.88%
    US
    PASW
    -8.68%

    U.S. stock market update: Pheton down 10.00%

    Pheton fell 10.00%; LifeMD fell 44.26%, with a transaction volume of USD 5.87 million; Veeva Systems -CL fell 0.17%, with a transaction volume of USD 4.572 million; Doximity fell 1.09%, with a transaction volume of USD 2.435 million; Waystar fell 2.07%, with a market value of USD 5.943 billion

    Tracking Unusual Activity·
    US
    PTHL
    0.00%
    US
    ITOC
    -2.88%
    Tracking Unusual Activity·
    US
    PTHL
    0.00%
    US
    ITOC
    -2.88%

    U.S. stock market update: Pheton up 14.00%

    Pheton rose 14.00%; Veeva Systems -CL fell 0.32%, with a transaction volume of USD 6.878 million; Doximity fell 0.86%, with a transaction volume of USD 1.968 million; Teladoc fell 1.29%, with a transaction volume of USD 1.516 million; Waystar rose 0.72%, with a market value of USD 6.081 billion

    Tracking Unusual Activity·
    US
    PTHL
    0.00%
    US
    ITOC
    -2.88%
    Tracking Unusual Activity·
    US
    PTHL
    0.00%
    US
    ITOC
    -2.88%

    Pre-market hot trades in US stocks: CRISPR Therap down 8.36% in pre-market; Pheton up 7.00% in pre-market

    CRISPR Therap pre-market down 8.36%; Pheton pre-market up 7.00%; Adaptimmune Therap pre-market up 53.97%; Arteris pre-market up 47.62%; Dax Optical pre-market up 44.94%

    Tracking Unusual Activity·
    US
    CRSP
    -1.08%
    US
    PTHL
    0.00%
    US
    ITOC
    -2.88%
    Tracking Unusual Activity·
    US
    CRSP
    -1.08%
    US
    PTHL
    0.00%
    US
    ITOC
    -2.88%
    © 2026 Longbridge｜Disclaimer